Amgen Inc

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Amgen Inc is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Amgen Inc

Amgen Inc is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by ECULIZUMAB-AEEB. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: treatment patients, hemolytic uremic, antibody positive, bkemv indicated, paroxysmal nocturnal, hemoglobinuria pnh, syndrome ahus, generalized myasthenia. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
ECULIZUMAB-AEEB 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — INTRAVENOUS 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Amgen Inc

Brand nameGenericTypeRoute
BKEMV ECULIZUMAB-AEEB HUMAN PRESCRIPTION DRUG INTRAVENOUS

Frequently asked questions

How many FDA drug products does Amgen Inc make?
1 FDA drug label records name Amgen Inc as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Amgen Inc produce?
The most frequent active ingredients in this portfolio are ECULIZUMAB-AEEB.

Are Amgen Inc products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.